Category: Clinical Insights

63 posts found

FAIR Health Publishes Telemedicine Report

Looking at over 29 billion private health claims, this study found that claim lines related to telehealth rose 624% from 2014-2018.

Clinical Insights

NCCI Examines Impact of the ODG Formulary in Arizona and Tennessee

While the utilization of opioids and other problematic drugs decreased, similar drops were seen in states without closed formularies.

Clinical Insights

The Growing Utilization and Costs of Anticancer Medications

Though they’re only needed for special cases in workers’ comp, anticancer medications can easily exceed $10,000 per monthly fill.

Clinical Insights

Negative Impacts of Combining Antidepressants with Opioids and Benzodiazepines

Combining all three drugs can reduce claim closure rates to 58.3%, with average claim costs of $94,000.

Clinical Insights

The Impact of the Changing Workforce

The workforce is aging, getting younger, and gaining more women, all at once. What does that mean for claims management?

Clinical Insights

Tackling Topicals: Clinicians Takes Notice

Despite having little clinical impact, topical creams continue to be utilized widely in workers’ comp.

Clinical Insights

Troubling Trends for Benzodiazepines

Prescribing has doubled since 2003, overdose deaths quadrupled since 1996, and misuse accounts for 20% of benzodiazepine use.

Clinical Insights

JAMA Examines Association of Early Physical Therapy with Long-Term Opioid Use

An analysis of 90,000 private claims explores the relationship between early PT and reduced long-term opioid use in musculoskeletal pain.

Clinical Insights

New Guidelines for Opioid-Induced Constipation

The American Gastroenterological Association released guidance on properly prescribing medications for OIC.

Clinical Insights

JAMA Examines Persistent Opioid Use in Workers’ Comp Patients

A study of 9,596 claimants who filled an opioid prescription found that 30% were still taking opioids 90 days later.

Clinical Insights

CWCI Releases Polypharmacy Report

According to 2016-2017 data, over 20% of polypharmacy claims are over 10 years old, with more than 50% of them for patients aged 50 and older.

Clinical Insights

New Developments in Migraine Medications

A new wave of drugs that suppress CGRP proteins to reduce migraines could be on the horizon.

Clinical Insights

JAMA Study Questions the Effectiveness of Negative Pressure Wound Therapy

In a randomized clinical trial of 460 patients, researchers found the treatment to have similar impact on self-rated disability as standard wound dressing.

Clinical Insights

IQVIA Reports on Global Oncology Trends

Global spending on cancer therapies now exceeds $133 billion.

Clinical Insights

The Craze Over Kratom

Kratom continues to grow in popularity as a drug for pain and opioid withdrawal, despite concerns from the FDA, CDC and DEA.

Prev 1 2 3 4 5 Next